1. Home
  2. FLYE vs HOOK Comparison

FLYE vs HOOK Comparison

Compare FLYE & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLYE
  • HOOK
  • Stock Information
  • Founded
  • FLYE 2018
  • HOOK 2011
  • Country
  • FLYE United States
  • HOOK United States
  • Employees
  • FLYE N/A
  • HOOK N/A
  • Industry
  • FLYE Aerospace
  • HOOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLYE Industrials
  • HOOK Health Care
  • Exchange
  • FLYE Nasdaq
  • HOOK Nasdaq
  • Market Cap
  • FLYE 10.2M
  • HOOK 9.3M
  • IPO Year
  • FLYE 2024
  • HOOK 2019
  • Fundamental
  • Price
  • FLYE $0.61
  • HOOK $1.56
  • Analyst Decision
  • FLYE
  • HOOK Buy
  • Analyst Count
  • FLYE 0
  • HOOK 4
  • Target Price
  • FLYE N/A
  • HOOK $10.67
  • AVG Volume (30 Days)
  • FLYE 220.7K
  • HOOK 166.8K
  • Earning Date
  • FLYE 06-17-2025
  • HOOK 06-17-2025
  • Dividend Yield
  • FLYE N/A
  • HOOK N/A
  • EPS Growth
  • FLYE N/A
  • HOOK N/A
  • EPS
  • FLYE N/A
  • HOOK N/A
  • Revenue
  • FLYE $28,547,111.00
  • HOOK $9,351,000.00
  • Revenue This Year
  • FLYE N/A
  • HOOK N/A
  • Revenue Next Year
  • FLYE N/A
  • HOOK N/A
  • P/E Ratio
  • FLYE N/A
  • HOOK N/A
  • Revenue Growth
  • FLYE N/A
  • HOOK N/A
  • 52 Week Low
  • FLYE $0.33
  • HOOK $0.72
  • 52 Week High
  • FLYE $7.62
  • HOOK $8.50
  • Technical
  • Relative Strength Index (RSI)
  • FLYE N/A
  • HOOK 56.94
  • Support Level
  • FLYE N/A
  • HOOK $1.51
  • Resistance Level
  • FLYE N/A
  • HOOK $1.65
  • Average True Range (ATR)
  • FLYE 0.00
  • HOOK 0.14
  • MACD
  • FLYE 0.00
  • HOOK -0.02
  • Stochastic Oscillator
  • FLYE 0.00
  • HOOK 34.37

About FLYE Fly-E Group Inc. Common Stock

Fly-E Group Inc is an electric vehicle company that is principally engaged in designing, installing and selling smart electric motorcycles, electric bikes, electric scooters and related accessories under the brand Fly E-Bike. It also provides connectivity solutions and value-added services to their customers.

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.

Share on Social Networks: